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Abstract
C22H10Br4N4O3S, monoclinic, P21/c (no. 14), a = 9.3725(6) Å,
b = 20.0436(12) Å, c = 15.3281(11) Å, β = 102.896(6)°,
V = 2806.9(3) Å3, Z = 4, Rgt(F ) = 0.0575, wRref(F
2) = 0.1566,
T = 296 K.
CCDC no.: 2049436
The molecular structure is shown in the figure. Table 1
contains crystallographic data and Table 2 contains the list
of the atoms including atomic coordinates and displace-
ment parameters.
Source of material
A mixture of 1-phenyl-5-(thiophen-2-yl)-1H-pyrazole-
3-carbohydrazide (0.57 g, 2.0 mmol) and 4,5,6,7-
tetrabromoisobenzofuran-1,3-dione (0.93 g, 2.0 mmol) in
glacial acetic acid (10 mL) was refluxed for 6 h. The solid
obtained on cooling was collected by filtration, washed
with cold water, dried, and recrystallized from dime-
thylformamide to give colourless crystals (82%) of the title
compound.
Experimental details
Hydrogen atoms were identified in difference Fourier
syntheses. The methyl hydrogens and those bonded to
sp2 C and N atoms were idealized during refinement us-
ing options AFIX 137, and AFIX 43 respectively in the
SHELXL-2018 program [4]. The Uiso values of the
hydrogen atoms were set to 1.5Ueq(C) for methyl groups
and 1.2Ueq(C,N) for the rest.
Table : Data collection and handling.
Crystal: Colourless block
Size: . × . × . mm
Wavelength: Mo Kα radiation (. Å)
μ: . mm−
Diffractometer, scan mode: SuperNova, ω
θmax, completeness: .°, %
N(hkl)measured, N(hkl)unique, Rint: , , .
Criterion for Iobs, N(hkl)gt: Iobs >  σ(Iobs), 
N(param)refined: 
Programs: CrysAlisPRO [],
SHELX [, ], WinGX/ORTEP []
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Comment
Carbohydrazides containing the pyrazole ring system
have significant biological activities [5, 6]. Heterocycles
containing both pyrazoles and thiophene ring systems are
versatile intermediates in organic synthesis and havemany
medicinal applications [7–9]. Recently, the X-ray crystal
structures of related heterocycles containing the pyrazole
ring system have been reported by us [10–12].
The asymmetric unit of the crystal structure consists
of one molecule of the title compound and one molecule of
dimethylformamide solvent. The target molecule com-
prises tetrabromodioxoisoindolinyl (A [C1—C8, O1, O2, Br1
—Br4]), pyrazolyl (B [C10—C12, N3, N4]), thiophenyl (C [C13
—C16, S1]) and phenyl (D [C17—C22]) ring systems. In the
title molecule, fragments B, C and the carboxamide group
are almost co-planar with twist angles: carboxamide/
B = 3.9(8)° and B/C = 13.9(3)°. Ring systems A and D are
almost perpendicular to the B–C-carboxamide plane with
twist angles A/B = 90.56(12)° and B/D = 79.97(16)°.
In the crystal, an intermolecular N–H···O hydrogen
bond occurs between the target and solventmolecules. The
associated geometry is N2···O4 = 2.808(6) Å, N2–H2···
O4 = 143.7°.
Close C–H···O interactions with geometry: (C14···
O1 = 3.259(6) Å, C14–H14···O1 = 170.7°) and (C16···
O3 = 3.266(6) Å, C16–H16···O3 = 146.4°) linkmolecules in the
[100] direction. Two phenyl groups (D) of neighbouring
molecules, related by inversion symmetry, are involved in a
π-π contact with a centroid-centroid distance of 3.65 Å.
The tetrabromodioxoisoindolinyl group (A) of one
molecule is also involved in π-π contacts on both sides. On
one side is a crystallographically independent group of a
molecule related by inversion symmetry (A–A interplanar
distance = 3.67 Å) and on the other side is a thiophenyl
group (A-[C2,C3,C5,C6,C7,C8 ring] centroid-to-centroid
distance = 3.61 Å).
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Table : Fractional atomic coordinates and isotropic or equivalent
isotropic displacement parameters (Å).
Atom X Y z Uiso*/Ueq
C . () . () . () . ()
C . () . () . () . ()
C . () . () . () . ()
C . () . () . () . ()
C . () . () −. () . ()
C −. () . () −. () . ()
C −. () . () −. () . ()
C −. () . () . () . ()
C . () . () . () . ()
C . () . () . () . ()
C . () . () . () . ()
H . . . .*
C . () . () . () . ()
C . () . () . () . ()
C . () . () . () . ()
H . . . .*
C . () . () . () . ()
H . . . .*
C . () . () . () . ()
H . . . .*
C . () . () . () . ()
C . () . () . () . ()
H . . . .*
C . () . () . () . ()
H . . . .*
C . () . () . () . ()
H . . . .*
C . () . () . () . ()
H . . . .*
C . () . () . () . ()
H . . . .*
C . () . () . () . ()
H . . . .*
C . () . () . () . ()
HA . . . .*
HB . . . .*
HC . . . .*
C . () . () . () . ()
HA . . . .*
HB . . . .*
HC . . . .*
N . () . () . () . ()
N . () . () . () . ()
H . . . .*
N . () . () . () . ()
N . () . () . () . ()
N . () . () . () . ()
O . () . () . () . ()
O . () . () . () . ()
O . () . () . () . ()
O . () . () . () . ()
Br . () . () −. () . ()
Br −. () . () −. () . ()
Table : (continued)
Atom X Y z Uiso*/Ueq
Br −. () . () −. () . ()
Br −. () . () . () . ()
S . () . () . () . ()
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